N-(1-ethyl-1,2,4-triazol-3-yl)-2-[hydroxy(diphenyl)methyl]-5-methoxy-1-methylimidazo[4,5-b]pyridine-6-carboxamide
C26H25N7O3 — CID 168678824
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(1-ethyl-1,2,4-triazol-3-yl)-2-[hydroxy(diphenyl)methyl]-5-methoxy-1-methylimidazo[4,5-b]pyridine-6-carboxamide
N-(1-ethyl-1,2,4-triazol-3-yl)-2-[hydroxy(diphenyl)methyl]-5-methoxy-1-methylimidazo[4,5-b]pyridine-6-carboxamide (PubChem CID 168678824) has the molecular formula C26H25N7O3 and a molecular weight of 483.53 g/mol. Its IUPAC name is N-(1-ethyl-1,2,4-triazol-3-yl)-2-[hydroxy(diphenyl)methyl]-5-methoxy-1-methylimidazo[4,5-b]pyridine-6-carboxamide.
Molecular Properties
| Compound Name | N-(1-ethyl-1,2,4-triazol-3-yl)-2-[hydroxy(diphenyl)methyl]-5-methoxy-1-methylimidazo[4,5-b]pyridine-6-carboxamide |
|---|---|
| PubChem CID | 168678824 |
| Molecular Formula | C26H25N7O3 |
| Molecular Weight | 483.53 g/mol |
| Exact Mass | 483.20 |
| IUPAC Name | N-(1-ethyl-1,2,4-triazol-3-yl)-2-[hydroxy(diphenyl)methyl]-5-methoxy-1-methylimidazo[4,5-b]pyridine-6-carboxamide |
| SMILES | CCn1cnc(NC(=O)c2cc3c(nc2OC)nc(C(O)(c2ccccc2)c2ccccc2)n3C)n1 |
| InChI | InChI=1S/C26H25N7O3/c1-4-33-16-27-25(31-33)30-22(34)19-15-20-21(28-23(19)36-3)29-24(32(20)2)26(35,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-16,35H,4H2,1-3H3,(H,30,31,34) |
| InChIKey | KQOYXFMSPVAWKD-UHFFFAOYSA-N |
| XLogP | 3.12 |
| TPSA | 119.98 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.53 |
| LogP ≤ 5 | 3.12 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168678824 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.